Literature DB >> 1881140

Liver bacterial clearance following hepatic artery ligation and portacaval shunt.

S Katz1, M A Jimenez, W E Lehmkuhler, J L Grosfeld.   

Abstract

The reticuloendothelial system (RES) plays an important role in removing bacteria, endotoxins, and immune complexes from the circulation. Hepatic phagocytosis accounts for more than 80% of RES function. The dual hepatic blood supply (hepatic artery/portal vein) may be altered by pathologic states and surgical procedures. This study evaluates and compares the effect of hepatic artery ligation and portacaval shunt on hepatic trapping of viable Escherichia coli. Thirty rats were placed in three groups: Group I was composed of sham operated controls; Group II underwent end-to-side portacaval shunt (PCS); and in Group III, hepatic artery ligation (HAL) was performed. At 2 weeks following the operation 10(9) 35S-radiolabeled viable E. coli were injected via the tail vein. At 10 min, bacterial distribution in the different organs was determined. Tissue samples were processed for liquid scintillation counting. The final distribution of bacteria was calculated from the input specific activity (dpm/bacteria) and expressed as the mean percentage of injected viable E. coli per gram of tissue and per organ weight. There was a significant decrease of bacterial trapping by the liver in rats following PCS (Group II), 45.0 +/- 10.4% vs controls 77.1 +/- 3.73% (P less than 0.005). This was partially compensated for by a significant increase of bacterial trapping by the lung. The decreased clearance in PCS rats is due to a reduction in liver mass compared to that in controls. Bacterial localization in HAL (Group III) rats was similar to that in controls. These data show that PCS decreases hepatic clearance and increases pulmonary localization of viable E. coli. This phagocytic dysfunction may contribute to increased susceptibility to infection following portacaval shunt.

Entities:  

Mesh:

Year:  1991        PMID: 1881140     DOI: 10.1016/0022-4804(91)90105-u

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

1.  Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia.

Authors:  Alix Ashare; Clark Stanford; Patricia Hancock; Donna Stark; Kathleen Lilli; Emily Birrer; Amanda Nymon; Kevin C Doerschug; Gary W Hunninghake
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

2.  Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis.

Authors:  Gabriela Barrera; Verónica Landoni; Daiana Martire-Greco; Paula Chiarella; Roberto Meiss; Sonia A Gómez; Fernanda Alves-Rosa; Barbara Rearte; Martín Isturiz; Marina S Palermo; Gabriela C Fernández
Journal:  Infect Immun       Date:  2010-12-20       Impact factor: 3.441

Review 3.  Bloodstream infections in patients with liver cirrhosis.

Authors:  Michele Bartoletti; Maddalena Giannella; Russell Edward Lewis; Pierluigi Viale
Journal:  Virulence       Date:  2016-02-11       Impact factor: 5.882

4.  Deer antler based active ingredients have protective effects on LPS/d-GalN-induced acute liver injury in mice through MAPK and NF-κB signalling pathways.

Authors:  Guixiang He; Quanmin Zhao; Yan Zhao; Ying Zong; Shigang Gu; Mengjie Li; Renjie Li; Jiaxin Sun
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

5.  An intensive medical care network led to successful living-donor liver transplantation in late-onset hepatic failure with disseminated Staphylococcus aureus infection.

Authors:  Rie Kure; Natsumi Uehara; Kazuaki Inoue; Tomomi Kogiso; Kazuhisa Kodama; Makiko Taniai; Katsutoshi Tokushige; Masayuki Nakano; Hiroto Egawa; Masakazu Yamamoto
Journal:  Clin J Gastroenterol       Date:  2018-09-14

Review 6.  Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation.

Authors:  Jonathan Mandel; Martina Casari; Maria Stepanyan; Alexey Martyanov; Carsten Deppermann
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

Review 7.  Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients.

Authors:  Aritz Perez Ruiz de Garibay; Andreas Kortgen; Julia Leonhardt; Alexander Zipprich; Michael Bauer
Journal:  Crit Care       Date:  2022-09-26       Impact factor: 19.334

Review 8.  Clinical review: The liver in sepsis.

Authors:  Nicolas Nesseler; Yoann Launey; Caroline Aninat; Fabrice Morel; Yannick Mallédant; Philippe Seguin
Journal:  Crit Care       Date:  2012-10-30       Impact factor: 9.097

9.  Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance.

Authors:  Connie H Y Wong; Craig N Jenne; Björn Petri; Navina L Chrobok; Paul Kubes
Journal:  Nat Immunol       Date:  2013-06-16       Impact factor: 25.606

Review 10.  Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.

Authors:  Jiachen Liu; Yantao Xu; Bimei Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.